查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2037529

2034年外科手術機器人市場預測－全球分析（按組件、產品類型、手術流程、控制機制、移動性、應用、最終用戶和地區分類）

Surgical Robotics Market Forecasts to 2034 - Global Analysis By Component, Product Type, Surgery Type, Control Mechanism, Mobility, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球手術機器人市場規模將達到 167 億美元，並在預測期內以 15.8% 的複合年成長率成長，到 2034 年將達到 541 億美元。

手術機器人是電腦輔助系統的統稱，它使外科醫生能夠以更高的精確度、靈活性和可視性進行微創手術。這些先進的平台整合了機械臂、專用器械和複雜的軟體，可以將外科醫生的動作轉化為患者體內精準的操作。市場涵蓋完整的機器人系統、可重複使用和一次性使用的器械，以及包括安裝、培訓和持續維護在內的綜合服務，服務範圍涵蓋泌尿系統、婦科、整形外科和普通外科等多個外科專科。

對微創手術的需求日益成長

患者對切口更小、出血量更少、住院時間更短、恢復時間更短等優勢手術技術的偏好，持續推動手術機器人系統的應用。臨床證據表明，機器人開放性手術手術。醫院和手術中心意識到，提供機器人手術選項能夠吸引患者和經驗豐富的外科醫生，從而帶來競爭優勢。隨著越來越多的同行評審研究證實機器人手術的益處，這一趨勢正在加速發展，促使醫療機構儘管前期投入巨大，仍願意投資建造機器人手術基礎設施。

極高的資本投資與維護成本

手術機器人系統的引進和維護會帶來巨大的經濟負擔，這限制了其市場滲透，尤其是在小規模的醫院和發展中地區。初始系統成本通常在150萬美元到250萬美元之間，而每年的維修合約又會使每台機器人的成本增加數十萬美元。此外，每次手術中使用的耗材都會產生持續的營運成本，有時每次手術的成本超過2000美元，進而影響醫院的獲利能力。這種成本結構迫使醫療機構管理者根據手術數量和報銷率仔細評估機器人投資的合理性，這在對價格敏感的市場中減緩了機器人的普及速度，因為患者數量可能不足以支撐所需的財務支出。

拓展至新興適應症及專科領域

除了機器人手術的核心領域之外，尚未開發的臨床領域也蘊藏手術機器人製造商的巨大成長潛力。整形外科、脊椎外科和神經外科手術正日益受益於機器人導航系統，該系統能夠提高植入的精確度。兒童手術、器官移植和顯微血管吻合術等新興應用領域也展現出良好的前景，並持續擴大目標市場。專為門診診所和手術中心設計的小型化、更專業的機器人平台正變得越來越普及，填補了以往服務不足的空白。隨著技術的微型化和成本的逐步降低，新的臨床路徑將不斷湧現，為成功進入這些新興應用領域的公司創造巨大的商機。

由於出現了其他外科手術技術，競爭異常激烈。

傳統腹腔鏡手術、手持式智慧型器械和非機器人電腦輔助導航系統憑藉著更低的成本和更好的治療效果，對機器人市場的主導地位構成了真正的威脅。腹腔鏡手術技術透過光學元件、關節式器械和人體工學改進不斷發展，逐漸縮小與機器人系統的性能差距。磁導航和軟性腔機器人等新興技術為某些手術提供了替代方案。此外，關鍵機器人技術專利的到期加劇了價格競爭，使得競爭對手能夠以更低的成本進入市場。這種競爭格局迫使現有主要企業不斷創新並降低成本，以抵禦強大的非機器人技術和替代機器人解決方案的衝擊，從而維持其市場地位。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對外科手術機器人市場造成了重大衝擊，醫院為了集中資源應對疫情而延後了擇期手術。疫情初期，機器人手術數量驟減，導致對器械、配件和系統的需求下降。然而，儘管旅行限制阻礙了專家的診療，但疫情加速了遠距手術培訓、遠距教學和遠端操作技術的應用。醫療機構認知到機器人技術的價值，它可以透過遠端主機操作降低手術團隊的感染風險。隨著擇期手術的恢復，在需求反彈和對高效精準手術的重新關注的推動下，市場強勁復甦，為疫情後的持續成長奠定了堅實的基礎。

在預測期內，機器人系統細分市場預計將佔據最大的市場佔有率。

預計在預測期內，機器人系統領域將佔據最大的市場佔有率，並且是部署手術機器人的核心資本資產。這些綜合平台包括手術主機、帶有機械臂的病人側推車組件、高清3D視覺系統以及用於運動縮放和防手震的整合軟體。儘管其銷量低於一次性器械，因為系統部署通常需要每台設備超過100萬美元的巨額初始投資，但該領域在收入方面仍佔據主導地位。啟動機器人手術專案的醫院將系統採購視為必要的基礎設施，以確保在系統整個運作週期內能夠持續獲得器械和配件的收入。

在預測期內，手術規劃和模擬系統領域預計將呈現最高的複合年成長率。

在預測期內，手術規劃和模擬系統領域預計將呈現最高的成長率，這主要得益於人們日益認知到術前準備直接影響手術結果和效率。這些軟體平台使外科醫生能夠在進入手術室前創建患者特異性的解剖模型、模擬手術過程、演練複雜操作並最佳化器械軌跡。人工智慧 (AI) 和機器學習演算法的整合實現了預測分析，用於評估併發症風險和預估手術時間。基於結果的獎勵模型獎勵治療效果的改善和併發症的減少，醫療機構正在增加對規劃系統的投入，以提高手術精度，同時縮短手術時間和降低再次手術率，從而加速了這些系統在各個專科領域的應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其完善的醫療保健基礎設施、有利的報銷政策以及主要機器人製造商的集中佈局。美國每年進行的機器人手術數量居全球之首，這主要歸功於達文西手術系統在泌尿系統和婦科的廣泛應用。充足的研究經費、積極採用新技術的文化以及患者願意長途跋涉接受機器人手術，都鞏固了其市場主導地位。此外，直覺外科（Intuitive Surgical）、史賽克（Stryker）和美敦力（Medtronic）等主要公司在該地區設有總部或重要業務機構，透過促進快速創新、臨床培訓和服務支持，進一步鞏固了它們在預測期內北美市場的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療保健體系的快速發展、醫療旅遊的日益興盛以及政府對先進外科技術投資的不斷增加。在中國、印度、日本和韓國等國家，隨著中產階級的壯大和對高品質醫療服務的需求不斷成長，機器人手術計畫正在各大都市醫院迅速推廣。醫療設備核准的寬鬆監管流程以及透過本地製造夥伴關係降低的系統成本，正在加速機器人手術的普及。該地區癌症、泌尿系統和婦科疾病病例數量龐大，擁有極為廣泛的患者群體。隨著國際製造商建立區域培訓中心，以及國內競爭對手推出成本更低的替代方案，亞太地區正在崛起為外科機器人領域成長最快的市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球手術機器人市場：依組件分類

  • 機器人系統
  • 設備和配件
  • 服務

第6章 全球手術機器人市場：依產品類型分類

  • 手術機器人系統
  • 手術導引系統
  • 手術計劃和模擬系統
  • 復健機器人系統

第7章 全球手術機器人市場：依手術類型分類

  • 微創手術
  • 開放性手術支持
  • 腹腔鏡手術
  • 內視鏡手術

第8章 全球手術機器人市場：依控制方式分類

  • 電腦控制系統
  • 直接遙控機械手臂系統
  • 監控系統

第9章 全球手術機器人市場：依移動性分類

  • 靜止系統
  • 行動/可攜式系統

第10章 全球手術機器人市場：依應用分類

  • 一般外科
  • 泌尿系統手術
  • 婦科手術
  • 整形外科手術
  • 神經外科
  • 心胸外科
  • 其他用途

第11章 全球手術機器人市場：以最終用戶分類

  • 醫院
  • 門診手術中心（ASC）
  • 專科診所
  • 研究和學術機構

第12章 全球手術機器人市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第13章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第14章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第15章：公司簡介

  • Intuitive Surgical Inc
  • Stryker Corporation
  • Medtronic plc
  • Zimmer Biomet Holdings Inc
  • Smith & Nephew plc
  • Johnson & Johnson
  • Asensus Surgical Inc
  • CMR Surgical Ltd
  • Accuray Incorporated
  • TransEnterix Inc
  • Think Surgical Inc
  • Renishaw plc
  • Medrobotics Corporation
  • Titan Medical Inc
  • Corindus Vascular Robotics Inc
Product Code: SMRC35944

According to Stratistics MRC, the Global Surgical Robotics Market is accounted for $16.7 billion in 2026 and is expected to reach $54.1 billion by 2034 growing at a CAGR of 15.8% during the forecast period. Surgical robotics encompasses computer-assisted systems that enable surgeons to perform minimally invasive procedures with enhanced precision, dexterity, and visualization. These advanced platforms integrate robotic arms, specialized instruments, and sophisticated software to translate surgeon movements into precise actions within the patient's body. The market includes complete robotic systems, reusable and disposable instruments, and comprehensive service offerings spanning installation, training, and ongoing maintenance across various surgical specialties including urology, gynecology, orthopedics, and general surgery.

Market Dynamics:

Driver:

Rising demand for minimally invasive surgeries

Growing patient preference for procedures that offer smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times continues to drive adoption of surgical robotic systems. Traditional open surgeries are increasingly being replaced by robotic-assisted approaches as clinical evidence demonstrates superior outcomes in many procedures, including prostatectomies, hysterectomies, and colorectal surgeries. Hospitals and surgical centers recognize the competitive advantage of offering robotic options to attract both patients and top surgical talent. The expanding body of peer-reviewed research validating robotic surgery benefits further accelerates this trend, pushing healthcare providers to invest in robotic infrastructure despite substantial upfront costs.

Restraint:

Prohibitively high capital and maintenance costs

The substantial financial burden associated with acquiring and maintaining surgical robotic systems limits market penetration, particularly in smaller hospitals and developing regions. Initial system costs typically range from $1.5 million to $2.5 million, with annual service contracts adding several hundred thousand dollars per robot. Additionally, disposable instruments used in each procedure generate ongoing operational expenses that can exceed $2,000 per surgery, impacting hospital profit margins. This cost structure forces healthcare administrators to carefully justify robotic investments based on procedure volumes and reimbursement rates, slowing adoption in price-sensitive markets where patient volumes may not support the required financial outlay.

Opportunity:

Expansion into emerging applications and specialties

Untapped clinical areas beyond established robotic strongholds present significant growth potential for surgical robotics manufacturers. Orthopedic, spinal, and neurosurgical procedures are increasingly benefiting from robotic guidance systems that enhance implant placement accuracy. Emerging applications in pediatric surgery, transplant procedures, and microvascular anastomosis are demonstrating promising results, expanding the addressable market. Smaller, specialty-specific robotic platforms designed for outpatient settings and ambulatory surgical centers are gaining traction, addressing previously underserved segments. As technological miniaturization continues and costs gradually decline, new clinical pathways will open, creating substantial revenue opportunities for companies that successfully enter these developing application areas.

Threat:

Intense competition from alternative surgical technologies

Traditional laparoscopy, handheld smart instruments, and non-robotic computer-assisted navigation systems pose credible threats to robotic market dominance by offering improved outcomes at lower costs. Laparoscopic techniques continue advancing with better optics, articulating instruments, and ergonomic enhancements that narrow the performance gap with robotic systems. Emerging technologies such as magnetic navigation and flexible endoluminal robots offer alternative approaches for specific procedures. Additionally, patent expirations on key robotic technologies enable competitor entry with lower-cost systems, intensifying price pressure. This competitive landscape forces continuous innovation and cost reduction from established players to maintain market positioning against viable non-robotic and alternative robotic solutions.

Covid-19 Impact:

The COVID-19 pandemic created significant disruption for surgical robotics markets as hospitals postponed elective procedures to conserve resources for pandemic response. Robotic surgery volumes declined sharply during initial outbreak phases, reducing demand for instruments, accessories, and system purchases. However, the pandemic also accelerated adoption of remote surgical training, telementoring, and teleoperated capabilities as travel restrictions limited expert access. Healthcare systems recognized the value of robotics in reducing surgical team exposure through remote console operation capabilities. As elective surgeries resumed, pent-up demand coupled with renewed focus on efficient, high-precision procedures drove strong market recovery, positioning surgical robotics favorably for sustained post-pandemic growth.

The Robotic Systems segment is expected to be the largest during the forecast period

The Robotic Systems segment is expected to account for the largest market share during the forecast period, representing the core capital equipment that forms the foundation of surgical robotics adoption. These comprehensive platforms include surgeon consoles, patient-side cart assemblies with robotic arms, high-definition 3D vision systems, and integrated software for motion scaling and tremor filtration. The substantial upfront investment required for system acquisition, typically exceeding $1 million per unit, ensures this segment maintains revenue dominance despite lower unit volumes compared to disposable instruments. Hospitals establishing robotic surgery programs prioritize system purchases as the essential infrastructure enabling subsequent recurring revenues from instruments and accessories throughout the system's operational lifetime.

The Surgical Planning & Simulation Systems segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Surgical Planning & Simulation Systems segment is predicted to witness the highest growth rate, driven by increasing recognition that preoperative preparation directly impacts surgical outcomes and efficiency. These software platforms enable surgeons to create patient-specific anatomical models, simulate procedure steps, rehearse complex maneuvers, and optimize instrument trajectories before entering the operating room. Integration of artificial intelligence and machine learning algorithms allows predictive analytics for complication risk assessment and procedural time estimation. As value-based reimbursement models reward improved outcomes and reduced complications, healthcare providers increasingly invest in planning systems that enhance surgical precision while reducing operative time and revision rates, accelerating adoption across multiple specialties.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by well-established healthcare infrastructure, favorable reimbursement policies, and concentrated presence of leading robotic manufacturers. The United States performs the highest annual volume of robotic procedures globally, driven by widespread da Vinci system penetration across urology and gynecology. Strong research funding, early technology adoption culture, and patient willingness to travel for robotic options contribute to market leadership. Additionally, major industry players including Intuitive Surgical, Stryker, and Medtronic maintain headquarters and significant operations in the region, facilitating rapid innovation, clinical training, and service support that reinforces North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly modernizing healthcare systems, rising medical tourism, and increasing government investments in advanced surgical technologies. Countries including China, India, Japan, and South Korea are aggressively expanding robotic surgery programs in major metropolitan hospitals, driven by growing middle-class populations demanding premium healthcare services. Favorable regulatory pathways for device approval and decreasing system costs through local manufacturing partnerships accelerate adoption. The region's high volume of cancer, urological, and gynecological cases creates substantial addressable patient populations. As international manufacturers establish regional training centers and domestic competitors introduce lower-cost alternatives, Asia Pacific emerges as the fastest-growing market for surgical robotics.

Key players in the market

Some of the key players in Surgical Robotics Market include Intuitive Surgical Inc, Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings Inc, Smith & Nephew plc, Johnson & Johnson, Asensus Surgical Inc, CMR Surgical Ltd, Accuray Incorporated, TransEnterix Inc, Think Surgical Inc, Renishaw plc, Medrobotics Corporation, Titan Medical Inc, and Corindus Vascular Robotics Inc.

Key Developments:

In March 2026, Medtronic received FDA clearance for the Stealth AXiS Surgical System, specifically for cranial and ENT (Ear, Nose, and Throat) procedures, expanding its navigation and robotics portfolio.

In January 2026, J&J submitted the OTTAVA Robotic Surgical System to the FDA for De Novo classification. The application targets marketing authorization for multiple general surgery procedures in the upper abdomen.

In November 2025, Stryker successfully integrated its $4.9 billion acquisition of Inari Medical, strengthening its MedSurg and Neurotechnology segment, which saw a 15.7% sales increase in 2025.

Components Covered:

  • Robotic Systems
  • Instruments & Accessories
  • Services

Product Types Covered:

  • Surgical Robotic Systems
  • Surgical Navigation Systems
  • Surgical Planning & Simulation Systems
  • Rehabilitation Robotic Systems

Surgery Types Covered:

  • Minimally Invasive Surgery
  • Open Surgery Assistance
  • Laparoscopic Surgery
  • Endoscopic Surgery

Control Mechanisms Covered:

  • Computer-Controlled Systems
  • Direct Telemanipulator Systems
  • Supervisory-Controlled Systems

Mobility's Covered:

  • Stationary Systems
  • Mobile/Portable Systems

Applications Covered:

  • General Surgery
  • Urology Surgery
  • Gynecology Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Cardiothoracic Surgery
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Research & Academic Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Surgical Robotics Market, By Component

  • 5.1 Robotic Systems
  • 5.2 Instruments & Accessories
  • 5.3 Services

6 Global Surgical Robotics Market, By Product Type

  • 6.1 Surgical Robotic Systems
  • 6.2 Surgical Navigation Systems
  • 6.3 Surgical Planning & Simulation Systems
  • 6.4 Rehabilitation Robotic Systems

7 Global Surgical Robotics Market, By Surgery Type

  • 7.1 Minimally Invasive Surgery
  • 7.2 Open Surgery Assistance
  • 7.3 Laparoscopic Surgery
  • 7.4 Endoscopic Surgery

8 Global Surgical Robotics Market, By Control Mechanism

  • 8.1 Computer-Controlled Systems
  • 8.2 Direct Telemanipulator Systems
  • 8.3 Supervisory-Controlled Systems

9 Global Surgical Robotics Market, By Mobility

  • 9.1 Stationary Systems
  • 9.2 Mobile/Portable Systems

10 Global Surgical Robotics Market, By Application

  • 10.1 General Surgery
  • 10.2 Urology Surgery
  • 10.3 Gynecology Surgery
  • 10.4 Orthopedic Surgery
  • 10.5 Neurosurgery
  • 10.6 Cardiothoracic Surgery
  • 10.7 Other Applications

11 Global Surgical Robotics Market, By End User

  • 11.1 Hospitals
  • 11.2 Ambulatory Surgical Centers (ASCs)
  • 11.3 Specialty Clinics
  • 11.4 Research & Academic Institutes

12 Global Surgical Robotics Market, By Geography

  • 12.1 North America
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Mexico
  • 12.2 Europe
    • 12.2.1 United Kingdom
    • 12.2.2 Germany
    • 12.2.3 France
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Netherlands
    • 12.2.7 Belgium
    • 12.2.8 Sweden
    • 12.2.9 Switzerland
    • 12.2.10 Poland
    • 12.2.11 Rest of Europe
  • 12.3 Asia Pacific
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 South Korea
    • 12.3.5 Australia
    • 12.3.6 Indonesia
    • 12.3.7 Thailand
    • 12.3.8 Malaysia
    • 12.3.9 Singapore
    • 12.3.10 Vietnam
    • 12.3.11 Rest of Asia Pacific
  • 12.4 South America
    • 12.4.1 Brazil
    • 12.4.2 Argentina
    • 12.4.3 Colombia
    • 12.4.4 Chile
    • 12.4.5 Peru
    • 12.4.6 Rest of South America
  • 12.5 Rest of the World (RoW)
    • 12.5.1 Middle East
      • 12.5.1.1 Saudi Arabia
      • 12.5.1.2 United Arab Emirates
      • 12.5.1.3 Qatar
      • 12.5.1.4 Israel
      • 12.5.1.5 Rest of Middle East
    • 12.5.2 Africa
      • 12.5.2.1 South Africa
      • 12.5.2.2 Egypt
      • 12.5.2.3 Morocco
      • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

  • 13.1 Industry Value Network and Supply Chain Assessment
  • 13.2 White-Space and Opportunity Mapping
  • 13.3 Product Evolution and Market Life Cycle Analysis
  • 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

  • 14.1 Mergers and Acquisitions
  • 14.2 Partnerships, Alliances, and Joint Ventures
  • 14.3 New Product Launches and Certifications
  • 14.4 Capacity Expansion and Investments
  • 14.5 Other Strategic Initiatives

15 Company Profiles

  • 15.1 Intuitive Surgical Inc
  • 15.2 Stryker Corporation
  • 15.3 Medtronic plc
  • 15.4 Zimmer Biomet Holdings Inc
  • 15.5 Smith & Nephew plc
  • 15.6 Johnson & Johnson
  • 15.7 Asensus Surgical Inc
  • 15.8 CMR Surgical Ltd
  • 15.9 Accuray Incorporated
  • 15.10 TransEnterix Inc
  • 15.11 Think Surgical Inc
  • 15.12 Renishaw plc
  • 15.13 Medrobotics Corporation
  • 15.14 Titan Medical Inc
  • 15.15 Corindus Vascular Robotics Inc

List of Tables

  • Table 1 Global Surgical Robotics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Surgical Robotics Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Surgical Robotics Market Outlook, By Robotic Systems (2023-2034) ($MN)
  • Table 4 Global Surgical Robotics Market Outlook, By Instruments & Accessories (2023-2034) ($MN)
  • Table 5 Global Surgical Robotics Market Outlook, By Services (2023-2034) ($MN)
  • Table 6 Global Surgical Robotics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 7 Global Surgical Robotics Market Outlook, By Surgical Robotic Systems (2023-2034) ($MN)
  • Table 8 Global Surgical Robotics Market Outlook, By Surgical Navigation Systems (2023-2034) ($MN)
  • Table 9 Global Surgical Robotics Market Outlook, By Surgical Planning & Simulation Systems (2023-2034) ($MN)
  • Table 10 Global Surgical Robotics Market Outlook, By Rehabilitation Robotic Systems (2023-2034) ($MN)
  • Table 11 Global Surgical Robotics Market Outlook, By Surgery Type (2023-2034) ($MN)
  • Table 12 Global Surgical Robotics Market Outlook, By Minimally Invasive Surgery (2023-2034) ($MN)
  • Table 13 Global Surgical Robotics Market Outlook, By Open Surgery Assistance (2023-2034) ($MN)
  • Table 14 Global Surgical Robotics Market Outlook, By Laparoscopic Surgery (2023-2034) ($MN)
  • Table 15 Global Surgical Robotics Market Outlook, By Endoscopic Surgery (2023-2034) ($MN)
  • Table 16 Global Surgical Robotics Market Outlook, By Control Mechanism (2023-2034) ($MN)
  • Table 17 Global Surgical Robotics Market Outlook, By Computer-Controlled Systems (2023-2034) ($MN)
  • Table 18 Global Surgical Robotics Market Outlook, By Direct Telemanipulator Systems (2023-2034) ($MN)
  • Table 19 Global Surgical Robotics Market Outlook, By Supervisory-Controlled Systems (2023-2034) ($MN)
  • Table 20 Global Surgical Robotics Market Outlook, By Mobility (2023-2034) ($MN)
  • Table 21 Global Surgical Robotics Market Outlook, By Stationary Systems (2023-2034) ($MN)
  • Table 22 Global Surgical Robotics Market Outlook, By Mobile / Portable Systems (2023-2034) ($MN)
  • Table 23 Global Surgical Robotics Market Outlook, By Application (2023-2034) ($MN)
  • Table 24 Global Surgical Robotics Market Outlook, By General Surgery (2023-2034) ($MN)
  • Table 25 Global Surgical Robotics Market Outlook, By Urology Surgery (2023-2034) ($MN)
  • Table 26 Global Surgical Robotics Market Outlook, By Gynecology Surgery (2023-2034) ($MN)
  • Table 27 Global Surgical Robotics Market Outlook, By Orthopedic Surgery (2023-2034) ($MN)
  • Table 28 Global Surgical Robotics Market Outlook, By Neurosurgery (2023-2034) ($MN)
  • Table 29 Global Surgical Robotics Market Outlook, By Cardiothoracic Surgery (2023-2034) ($MN)
  • Table 30 Global Surgical Robotics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 31 Global Surgical Robotics Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Surgical Robotics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 33 Global Surgical Robotics Market Outlook, By Ambulatory Surgical Centers (ASCs) (2023-2034) ($MN)
  • Table 34 Global Surgical Robotics Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 35 Global Surgical Robotics Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.